Colloquium: HIV and hepatitis C treatment as prevention

The promise, the pitfalls and the public health benefits

Wednesday 16 July 2014 09:00 – Wednesday 16 July 2014 15:00


The Event

Hosted by Burnet Institute, the annual Colloquium for the Centre for Research Excellence into Injecting Drug Use (CREIDU) will focus on ‘treatment as prevention’ – using treatment as a method of preventing the spread and harms of HIV and hepatitis C in people who inject drugs.

With an interactive format and exciting mix of speakers, the Colloquium is designed to draw together researchers, affected communities, policy makers and practitioners to discuss this exciting topic.

This event is a registered AIDS 2014 Affiliated Independent Event.

While tickets are free, registration is essential as there is a limited number of seats. Please visit the Burnet event page to register. 

Who Should Attend?

Open to the public.


Among the key speakers are:

  • Professor Gregory Dore

Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Australia.

  • Professor Lisa Maher

Program Head and NHMRC Senior Research Fellow, Viral Hepatitis Epidemiology and Prevention Program, Kirby Institute, UNSW, Australia.

  • Professor Frederick L. Altice

Professor of Medicine, Epidemiology and Public Health; Director of Clinical and Community Research; Yale University School of Medicine and School of Public Health; Section of Infectious Diseases, AIDS Program and Division of Epidemiology of Microbial Diseases, USA.

  • Niklas Luhmann

Harm Reduction and HIV/AIDS Advisor, Médecins du Monde, France.

  • Ms Annie Madden

Executive Officer of the Australian Injecting & Illicit Drug Users League (AIVL), Australia.

  • Professor Peter Vickerman

Professor in Infectious Disease Modelling at the University of Bristol and a member of LSHTM’s Social and Mathematical Epidemiology Group and the Centre for Research on Drugs and Health Behaviour (Faculty of Public Health and Policy), UK.

  • Professor Margaret Hellard

Head, Centre for Population Health, Burnet Institute; Burnet Associate Director; Adjunct Professor, Monash University, DEPM, Australia.

  • Professor Andrew Lloyd

AM, Director Inflammation and Infection Research Centre, UNSW; Visiting Medical Officer, Justice Health, New South Wales.

  • Mr Jack Wallace

Research Fellow, Australian Research Centre in Sex, Health and Society, Executive Member of the Coalition for the Eradication of Viral Hepatitis in Asia and the Pacific.

  • Dr Nicolas Clark

Medical Officer, Management of Substance Abuse, World Health Organization, Geneva

Date & Time

Wednesday 16 July 2014 09:00 – Wednesday 16 July 2014 15:00


Free (including catering)


AMREP Lecture Theatre
75 Commercial Road